Skip to main content
OpenTrials

Clinical trial condition

Castration-resistant Prostate Cancer

Explore clinical trials studying Castration-resistant Prostate Cancer. Study availability and eligibility vary by location and protocol.

65 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

Castration-resistant Prostate Cancer trial results

Completed

Phase I Study of LFA102 in Patients With Prolactin Receptor-positive Castration-resistant Prostate Cancer or Prolactin Receptor-positive Metastatic Breast Cancer

NCT01338831

Conditions
Breast Diseases, Breast Neoplasms, Castration-resistant Prostate Cancer, +19 more
Locations
  • Massachusetts General Hospital Mass Gen 3 Boston, Massachusetts, United States
  • Cancer Institute of New Jersey SC New Brunswick, New Jersey, United States
  • Thomas Jefferson University, Dept. of Phsyciatry & Neurology Thomas Jefferson Philadelphia, Pennsylvania, United States
  • University of Utah / Huntsman Cancer Institute Huntsman 3 Salt Lake City, Utah, United States
View Trial Details
Completed

Phase Ib of Abiraterone Acetate Plus BEZ235 or BKM120 in Castration-resistant Prostate Cancer (CRPC) Patients

NCT01634061

Conditions
Castration-resistant Prostate Cancer
Locations
  • Cedars Sinai Medical Center SC Los Angeles, California, United States
  • Hackensack University Medical Center Hackensack Univ Hackensack, New Jersey, United States
  • Novartis Investigative Site Brussels, Belgium
  • Novartis Investigative Site Wilrijk, Belgium
View Trial Details
Completed

A Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-resistant Prostate Cancer and Men With Metastatic Prostate Cancer

NCT02066961

Conditions
Castration-resistant Prostate Cancer, Genital Diseases, Genital Diseases, Male, +10 more
Locations
  • Site Algiers, Algeria
  • Site Algiers, Algeria
  • Site Blida, Algeria
  • Site Buenos Aires, Argentina
View all 93 locations
View Trial Details
Completed

Food Effect Study of Abiraterone Acetate for Treatment of Patients With Castration-Resistant Prostate Cancer

NCT01543776

Conditions
Castration-resistant Prostate Cancer, Genital Diseases, Genital Diseases, Male, +9 more
Locations
  • Emory University Winship Cancer Institute Atlanta, Georgia, United States
  • University of Chicago Chicago, Illinois, United States
  • North Shore University Health System Evanston, Illinois, United States
  • Ingalls Memorial Hospital Harvey, Illinois, United States
View Trial Details
Completed

Concurrent vs. Sequential Sipuleucel-T & Abiraterone Treatment in Men With Metastatic Castrate Resistant Prostate Cancer

NCT01487863

Conditions
Castration-resistant Prostate Cancer, Genital Diseases, Genital Diseases, Male, +10 more
Locations
  • UCSD Medical Center - La Jolla La Jolla, California, United States
  • Moores UCSD Cancer Center La Jolla, California, United States
  • Cancer Center Oncology Medical Group La Mesa, California, United States
  • UCSD Medical Center - Hillcrest San Diego, California, United States
View all 21 locations
View Trial Details

Related conditions